Boston Scientific's $3.7B Axonics Buy Under FTC Microscope

By Jade Martinez-Pogue · April 4, 2024, 3:50 PM EDT

Biomedical engineering company Boston Scientific Corp. on Thursday disclosed that the Federal Trade Commission requested more information on its planned $3.7 billion acquisition of medical technology company Axonics, which will result...

To view the full article, register now.